Aberrant right subclavian artery: Incidence and correlation with other markers of Down syndrome in second-trimester fetuses

D. Paladini, G. Sglavo, G. Pastore, A. Masucci, M. R. D'Armiento, C. Nappi

Research output: Contribution to journalArticle

Abstract

Objective To assess the incidence of aberrant right subclavian artery (ARSA) and other strong markers of Down syndrome and their correlation in a large population of second-trimester Down syndrome fetuses assessed in a tertiary referral center. Methods Presence or absence of ARSA and other major ultrasound markers of Down syndrome was assessed in a population of 106 second-trimester Down syndrome fetuses referred to our unit for expert assessment and/or termination of pregnancy after karyotyping performed for positive first- or second-trimester screening or advanced maternal age or on maternal request. All cases in which the diagnosis of Down syndrome followed the ultrasound detection of major anomalies or soft markers were excluded from the study, as were all cases with a gestational age less than 14 + 0 weeks. We searched for the ARSA on the three vessels and trachea view using color or power Doppler. All fetuses underwent a thorough anatomic assessment and fetal echocardiography. The other Down syndrome markers assessed were: absent or hypoplastic nasal bone (NB-), defined as length <5 th centile; nuchal fold ≥ 5 mm; and mild pyelectasis (> 5 mm). In addition, the presence of major cardiac and extracardiac defects was recorded. A correlation analysis was then performed in order to investigate possible associations between markers and/or major anomalies. Postmortem or postnatal diagnostic confirmation was available in all cases. Results The mean (SD) gestational age at ultrasound assessment was 20.4 (4.1) weeks. The incidence of the various variables in the population of Down syndrome fetuses was: ARSA, 25%; NB-, 43%; nuchal fold ≥ 5 mm, 16%; pyelectasis, 17%; major heart defects, 41%; atrioventricular septal defect, 25%; and extracardiac anomaly, 24%. The presence of ARSA did not correlate with any of the other variables. The only positive correlations (P <0.05) were between NB- and pyelectasis, and between cardiac and extracardiac defects. Conclusions This represents the largest Down syndrome population assessed for ARSA. In this series, the incidence of ARSA was 25%, lower than previously reported in much smaller series. Its presence did not correlate with the presence of any other marker or major anomaly, including heart defects.

Original languageEnglish
Pages (from-to)191-195
Number of pages5
JournalUltrasound in Obstetrics and Gynecology
Volume39
Issue number2
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Second Pregnancy Trimester
Down Syndrome
Fetus
Pyelectasis
Incidence
Nasal Bone
Nuchal Translucency Measurement
Population
Gestational Age
Karyotyping
Aberrant subclavian artery
Maternal Age
Trachea
Tertiary Care Centers
Echocardiography
Color
Mothers
Pregnancy

Keywords

  • aberrant right subclavian artery
  • ARSA
  • Down syndrome
  • nasal bone
  • nuchal fold

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Reproductive Medicine

Cite this

Aberrant right subclavian artery : Incidence and correlation with other markers of Down syndrome in second-trimester fetuses. / Paladini, D.; Sglavo, G.; Pastore, G.; Masucci, A.; D&apos;Armiento, M. R.; Nappi, C.

In: Ultrasound in Obstetrics and Gynecology, Vol. 39, No. 2, 02.2012, p. 191-195.

Research output: Contribution to journalArticle

Paladini, D. ; Sglavo, G. ; Pastore, G. ; Masucci, A. ; D&apos;Armiento, M. R. ; Nappi, C. / Aberrant right subclavian artery : Incidence and correlation with other markers of Down syndrome in second-trimester fetuses. In: Ultrasound in Obstetrics and Gynecology. 2012 ; Vol. 39, No. 2. pp. 191-195.
@article{f46cf56e9039427f91eabc1e4729634c,
title = "Aberrant right subclavian artery: Incidence and correlation with other markers of Down syndrome in second-trimester fetuses",
abstract = "Objective To assess the incidence of aberrant right subclavian artery (ARSA) and other strong markers of Down syndrome and their correlation in a large population of second-trimester Down syndrome fetuses assessed in a tertiary referral center. Methods Presence or absence of ARSA and other major ultrasound markers of Down syndrome was assessed in a population of 106 second-trimester Down syndrome fetuses referred to our unit for expert assessment and/or termination of pregnancy after karyotyping performed for positive first- or second-trimester screening or advanced maternal age or on maternal request. All cases in which the diagnosis of Down syndrome followed the ultrasound detection of major anomalies or soft markers were excluded from the study, as were all cases with a gestational age less than 14 + 0 weeks. We searched for the ARSA on the three vessels and trachea view using color or power Doppler. All fetuses underwent a thorough anatomic assessment and fetal echocardiography. The other Down syndrome markers assessed were: absent or hypoplastic nasal bone (NB-), defined as length <5 th centile; nuchal fold ≥ 5 mm; and mild pyelectasis (> 5 mm). In addition, the presence of major cardiac and extracardiac defects was recorded. A correlation analysis was then performed in order to investigate possible associations between markers and/or major anomalies. Postmortem or postnatal diagnostic confirmation was available in all cases. Results The mean (SD) gestational age at ultrasound assessment was 20.4 (4.1) weeks. The incidence of the various variables in the population of Down syndrome fetuses was: ARSA, 25{\%}; NB-, 43{\%}; nuchal fold ≥ 5 mm, 16{\%}; pyelectasis, 17{\%}; major heart defects, 41{\%}; atrioventricular septal defect, 25{\%}; and extracardiac anomaly, 24{\%}. The presence of ARSA did not correlate with any of the other variables. The only positive correlations (P <0.05) were between NB- and pyelectasis, and between cardiac and extracardiac defects. Conclusions This represents the largest Down syndrome population assessed for ARSA. In this series, the incidence of ARSA was 25{\%}, lower than previously reported in much smaller series. Its presence did not correlate with the presence of any other marker or major anomaly, including heart defects.",
keywords = "aberrant right subclavian artery, ARSA, Down syndrome, nasal bone, nuchal fold",
author = "D. Paladini and G. Sglavo and G. Pastore and A. Masucci and D&apos;Armiento, {M. R.} and C. Nappi",
year = "2012",
month = "2",
doi = "10.1002/uog.10053",
language = "English",
volume = "39",
pages = "191--195",
journal = "Ultrasound in Obstetrics and Gynecology",
issn = "0960-7692",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Aberrant right subclavian artery

T2 - Incidence and correlation with other markers of Down syndrome in second-trimester fetuses

AU - Paladini, D.

AU - Sglavo, G.

AU - Pastore, G.

AU - Masucci, A.

AU - D&apos;Armiento, M. R.

AU - Nappi, C.

PY - 2012/2

Y1 - 2012/2

N2 - Objective To assess the incidence of aberrant right subclavian artery (ARSA) and other strong markers of Down syndrome and their correlation in a large population of second-trimester Down syndrome fetuses assessed in a tertiary referral center. Methods Presence or absence of ARSA and other major ultrasound markers of Down syndrome was assessed in a population of 106 second-trimester Down syndrome fetuses referred to our unit for expert assessment and/or termination of pregnancy after karyotyping performed for positive first- or second-trimester screening or advanced maternal age or on maternal request. All cases in which the diagnosis of Down syndrome followed the ultrasound detection of major anomalies or soft markers were excluded from the study, as were all cases with a gestational age less than 14 + 0 weeks. We searched for the ARSA on the three vessels and trachea view using color or power Doppler. All fetuses underwent a thorough anatomic assessment and fetal echocardiography. The other Down syndrome markers assessed were: absent or hypoplastic nasal bone (NB-), defined as length <5 th centile; nuchal fold ≥ 5 mm; and mild pyelectasis (> 5 mm). In addition, the presence of major cardiac and extracardiac defects was recorded. A correlation analysis was then performed in order to investigate possible associations between markers and/or major anomalies. Postmortem or postnatal diagnostic confirmation was available in all cases. Results The mean (SD) gestational age at ultrasound assessment was 20.4 (4.1) weeks. The incidence of the various variables in the population of Down syndrome fetuses was: ARSA, 25%; NB-, 43%; nuchal fold ≥ 5 mm, 16%; pyelectasis, 17%; major heart defects, 41%; atrioventricular septal defect, 25%; and extracardiac anomaly, 24%. The presence of ARSA did not correlate with any of the other variables. The only positive correlations (P <0.05) were between NB- and pyelectasis, and between cardiac and extracardiac defects. Conclusions This represents the largest Down syndrome population assessed for ARSA. In this series, the incidence of ARSA was 25%, lower than previously reported in much smaller series. Its presence did not correlate with the presence of any other marker or major anomaly, including heart defects.

AB - Objective To assess the incidence of aberrant right subclavian artery (ARSA) and other strong markers of Down syndrome and their correlation in a large population of second-trimester Down syndrome fetuses assessed in a tertiary referral center. Methods Presence or absence of ARSA and other major ultrasound markers of Down syndrome was assessed in a population of 106 second-trimester Down syndrome fetuses referred to our unit for expert assessment and/or termination of pregnancy after karyotyping performed for positive first- or second-trimester screening or advanced maternal age or on maternal request. All cases in which the diagnosis of Down syndrome followed the ultrasound detection of major anomalies or soft markers were excluded from the study, as were all cases with a gestational age less than 14 + 0 weeks. We searched for the ARSA on the three vessels and trachea view using color or power Doppler. All fetuses underwent a thorough anatomic assessment and fetal echocardiography. The other Down syndrome markers assessed were: absent or hypoplastic nasal bone (NB-), defined as length <5 th centile; nuchal fold ≥ 5 mm; and mild pyelectasis (> 5 mm). In addition, the presence of major cardiac and extracardiac defects was recorded. A correlation analysis was then performed in order to investigate possible associations between markers and/or major anomalies. Postmortem or postnatal diagnostic confirmation was available in all cases. Results The mean (SD) gestational age at ultrasound assessment was 20.4 (4.1) weeks. The incidence of the various variables in the population of Down syndrome fetuses was: ARSA, 25%; NB-, 43%; nuchal fold ≥ 5 mm, 16%; pyelectasis, 17%; major heart defects, 41%; atrioventricular septal defect, 25%; and extracardiac anomaly, 24%. The presence of ARSA did not correlate with any of the other variables. The only positive correlations (P <0.05) were between NB- and pyelectasis, and between cardiac and extracardiac defects. Conclusions This represents the largest Down syndrome population assessed for ARSA. In this series, the incidence of ARSA was 25%, lower than previously reported in much smaller series. Its presence did not correlate with the presence of any other marker or major anomaly, including heart defects.

KW - aberrant right subclavian artery

KW - ARSA

KW - Down syndrome

KW - nasal bone

KW - nuchal fold

UR - http://www.scopus.com/inward/record.url?scp=84856354011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856354011&partnerID=8YFLogxK

U2 - 10.1002/uog.10053

DO - 10.1002/uog.10053

M3 - Article

C2 - 21793087

AN - SCOPUS:84856354011

VL - 39

SP - 191

EP - 195

JO - Ultrasound in Obstetrics and Gynecology

JF - Ultrasound in Obstetrics and Gynecology

SN - 0960-7692

IS - 2

ER -